Epstein–Barr virus (EBV) has the ability to promote cell cycle progression following the initial infection of primary resting B-lymphocytes and to cause cell cycle arrest at the onset of the viral replicative cycle. Various mechanisms have been proposed for the proliferative effects, including the up-regulation of cyclin D2 by the viral EBNA-2 and EBNA-LP proteins, direct binding of EBNA3C to the retinoblastoma protein (pRb), and down-regulation of the p16INK4A tumour suppressor by the viral LMP1 product. To try to gain insight into the relative importance of these mechanisms, the ability of EBV to immortalize lymphocytes from an individual who is genetically deficient for p16INK4A was examined. From detailed analyses of the resultant lymphoblastoid cell lines it is concluded that p16INK4A status has little bearing on EBV's ability to manipulate the cell cycle machinery and a model to accommodate the previously proposed routes taken by EBV to bypass the restriction point is presented.
AlcortaD. A.,
XiongY.,
PhelpsD.,
HannonG.,
BeachD.,
BarrettJ. C.1996; Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci U S A 93:13742–13747[CrossRef]
AndohT.2000; Signal transduction pathways leading to cell cycle arrest and apoptosis induced by DNA topoisomerase poisons. Cell Biochem Biophys 33:181–188[CrossRef]
BrookesS.,
RoweJ.,
RuasM.12 other authors2002; INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J 21:2936–2945[CrossRef]
CannellE. J.,
FarrellP. J.,
SinclairA. J.1996; Epstein–Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalisation of primary B-cells. Oncogene 13:1413–1421
CannellE. J.,
FarrellP. J.,
SinclairA. J.1998; Cell cycle arrest following exposure of EBV-immortalised B-cells to gamma irradiation correlates with inhibition of cdk2 activity. FEBS Lett 439:297–301[CrossRef]
FrostV.,
SinclairA. J.2000; p27KIP1 is down-regulated by two different mechanisms in human lymphoid cells undergoing apoptosis. Oncogene 19:3115–3120[CrossRef]
GruisN. A.,
VanderveldenP. A.,
SandkuijlL. A.,
PrinsD. E.,
WeaverfeldhausJ.,
KambA.,
BergmanW.,
FrantsR. R.1995; Homozygotes for Cdkn2 (P16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 10:351–353[CrossRef]
HaraE.,
SmithR.,
ParryD.,
TaharaH.,
StoneS.,
PetersG.1996; Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 16:859–867
KempkesB.,
SpitkovskyD.,
JansendurrP.,
EllwartJ. W.,
KremmerE.,
DelecluseH. J.,
RottenbergerC.,
BornkammG. W.,
HammerschmidtW.1995; B-cell proliferation and induction of early G1-regulating proteins by Epstein–Barr virus mutants conditional for EBNA2. EMBO J 14:88–96
LoughranO.,
MalliriA.,
OwensD.,
GallimoreP. H.,
StanleyM. A.,
OzanneB.,
FrameM. C.,
ParkinsonE. K.1996; Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene 13:561–568
PalmeroI.,
McConnellB.,
ParryD.,
BrookesS.,
HaraE.,
BatesS.,
JatP.,
PetersG.1997; Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene 15:495–503[CrossRef]
ParkerG. A.,
CrookT.,
BainM.,
SaraE. A.,
FarrellP. J.,
AlldayM. J.1996; Epstein–Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus EIA and papillomavirus E7. Oncogene 13:2541–2549
ReznikoffC. A.,
YeagerT. R.,
BelairC. D.,
SavelievaE.,
PuthenveettilJ. A.,
StadlerW. M.1996; Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res 56:2886–2890
SerranoM.,
HannonG. J.,
BeachD.1993; A new regulatory motif in cell-cycle control causing specific-inhibition of cyclin-D/Cdk4. Nature 366:704–707[CrossRef]
SinclairA. J.,
FarrellP. J.1995b; Methods to study Epstein–Barr virus and p53 status in human cells. In Methods in Molecular Genetics pp 89–100 Edited by
AldolphK. W.
New York: Academic Press;
SinclairA. J.,
PalmeroI.,
PetersG.,
FarrellP. J.1994; EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein–Barr virus. EMBO J 13:3321–3328
YangX. H.,
HeZ. M.,
XinB. Z.,
CaoL.2000; LMP1 of Epstein–Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression. Oncogene 19:2002–2013[CrossRef]